MITOS THERAPEUTICS Trademark

Trademark Overview


On Monday, March 25, 2024, a trademark application was filed for MITOS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MITOS THERAPEUTICS trademark a serial number of 79396791. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, April 15, 2025. This trademark is owned by Mitos Therapeutics Inc.. The MITOS THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

RNA interference technology research; drug discovery services; pharmaceutical research and development; scientific research in the field of pharmacy; technical research in the field of pharmaceutical studies; pharmaceutical drug development services; providing information on the testing, inspection and research of medical products; scientific research in the nature of conducting clinical trials for others; laboratory research services relating to dermatology; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs.
mitos therapeutics

General Information


Serial Number79396791
Word MarkMITOS THERAPEUTICS
Filing DateMonday, March 25, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, April 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesRNA interference technology research; drug discovery services; pharmaceutical research and development; scientific research in the field of pharmacy; technical research in the field of pharmaceutical studies; pharmaceutical drug development services; providing information on the testing, inspection and research of medical products; scientific research in the nature of conducting clinical trials for others; laboratory research services relating to dermatology; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 6, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMitos Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, June 6, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, October 9, 2024NON-FINAL ACTION WRITTEN
Monday, June 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 10, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, October 2, 2024ASSIGNED TO EXAMINER
Thursday, October 10, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 29, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, November 17, 2024REFUSAL PROCESSED BY IB
Friday, April 11, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 11, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 11, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, April 11, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 11, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 11, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 14, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 14, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 15, 2025SUSPENSION LETTER WRITTEN
Tuesday, April 15, 2025LETTER OF SUSPENSION E-MAILED
Tuesday, April 15, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 15, 2024REFUSAL PROCESSED BY MPU